Cargando…

Primary renal lymphoma: a population-based study in the United States, 1980–2013

Primary renal lymphoma (PRL) is a rare lymphoid malignancy with only a few cases reported in the literature. We performed a population-based study of PRL to determine its incidence, clinical characteristics and factors associated with survival using the Surveillance, Epidemiology, and End Results (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiayuan, Peng, Jiangtong, Zheng, Yongqiang, Li, Sen, Yang, Pengcheng, Wu, Xiangyi, Tian, He, Liu, Hui, Yang, Shengli, Wang, Wenjing, Wu, Bian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805900/
https://www.ncbi.nlm.nih.gov/pubmed/31641184
http://dx.doi.org/10.1038/s41598-019-51635-6
_version_ 1783461501431971840
author Chen, Jiayuan
Peng, Jiangtong
Zheng, Yongqiang
Li, Sen
Yang, Pengcheng
Wu, Xiangyi
Tian, He
Liu, Hui
Yang, Shengli
Wang, Wenjing
Wu, Bian
author_facet Chen, Jiayuan
Peng, Jiangtong
Zheng, Yongqiang
Li, Sen
Yang, Pengcheng
Wu, Xiangyi
Tian, He
Liu, Hui
Yang, Shengli
Wang, Wenjing
Wu, Bian
author_sort Chen, Jiayuan
collection PubMed
description Primary renal lymphoma (PRL) is a rare lymphoid malignancy with only a few cases reported in the literature. We performed a population-based study of PRL to determine its incidence, clinical characteristics and factors associated with survival using the Surveillance, Epidemiology, and End Results (SEER) database. We identified 723 patients with PRL. The most common histological subtype of PRL was diffuse large B-cell lymphoma (56.3%). The incidence and mortality rate of PRL was 0.053/100,000 person-years and 0.036/100,000 person-years, respectively. The incidence rate of PRL was increasing significantly with an annual percentage change (APC) of 3.45% (p < 0.001). The 1-year and 5-year relative survival (RS) rates of patients with PRL were 78% and 64%. The RS of patients diagnosed between 2000 to 2013 was better than that of patients diagnosed between 1980–1999. A multivariate Cox hazards regression analysis revealed that older age, male gender, diagnosis before 2000, advanced stage, not receiving surgical treatment, and DLBCL or T/NK cell lymphoma type were independent predictors of unfavorable survival.
format Online
Article
Text
id pubmed-6805900
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-68059002019-10-24 Primary renal lymphoma: a population-based study in the United States, 1980–2013 Chen, Jiayuan Peng, Jiangtong Zheng, Yongqiang Li, Sen Yang, Pengcheng Wu, Xiangyi Tian, He Liu, Hui Yang, Shengli Wang, Wenjing Wu, Bian Sci Rep Article Primary renal lymphoma (PRL) is a rare lymphoid malignancy with only a few cases reported in the literature. We performed a population-based study of PRL to determine its incidence, clinical characteristics and factors associated with survival using the Surveillance, Epidemiology, and End Results (SEER) database. We identified 723 patients with PRL. The most common histological subtype of PRL was diffuse large B-cell lymphoma (56.3%). The incidence and mortality rate of PRL was 0.053/100,000 person-years and 0.036/100,000 person-years, respectively. The incidence rate of PRL was increasing significantly with an annual percentage change (APC) of 3.45% (p < 0.001). The 1-year and 5-year relative survival (RS) rates of patients with PRL were 78% and 64%. The RS of patients diagnosed between 2000 to 2013 was better than that of patients diagnosed between 1980–1999. A multivariate Cox hazards regression analysis revealed that older age, male gender, diagnosis before 2000, advanced stage, not receiving surgical treatment, and DLBCL or T/NK cell lymphoma type were independent predictors of unfavorable survival. Nature Publishing Group UK 2019-10-22 /pmc/articles/PMC6805900/ /pubmed/31641184 http://dx.doi.org/10.1038/s41598-019-51635-6 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Chen, Jiayuan
Peng, Jiangtong
Zheng, Yongqiang
Li, Sen
Yang, Pengcheng
Wu, Xiangyi
Tian, He
Liu, Hui
Yang, Shengli
Wang, Wenjing
Wu, Bian
Primary renal lymphoma: a population-based study in the United States, 1980–2013
title Primary renal lymphoma: a population-based study in the United States, 1980–2013
title_full Primary renal lymphoma: a population-based study in the United States, 1980–2013
title_fullStr Primary renal lymphoma: a population-based study in the United States, 1980–2013
title_full_unstemmed Primary renal lymphoma: a population-based study in the United States, 1980–2013
title_short Primary renal lymphoma: a population-based study in the United States, 1980–2013
title_sort primary renal lymphoma: a population-based study in the united states, 1980–2013
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805900/
https://www.ncbi.nlm.nih.gov/pubmed/31641184
http://dx.doi.org/10.1038/s41598-019-51635-6
work_keys_str_mv AT chenjiayuan primaryrenallymphomaapopulationbasedstudyintheunitedstates19802013
AT pengjiangtong primaryrenallymphomaapopulationbasedstudyintheunitedstates19802013
AT zhengyongqiang primaryrenallymphomaapopulationbasedstudyintheunitedstates19802013
AT lisen primaryrenallymphomaapopulationbasedstudyintheunitedstates19802013
AT yangpengcheng primaryrenallymphomaapopulationbasedstudyintheunitedstates19802013
AT wuxiangyi primaryrenallymphomaapopulationbasedstudyintheunitedstates19802013
AT tianhe primaryrenallymphomaapopulationbasedstudyintheunitedstates19802013
AT liuhui primaryrenallymphomaapopulationbasedstudyintheunitedstates19802013
AT yangshengli primaryrenallymphomaapopulationbasedstudyintheunitedstates19802013
AT wangwenjing primaryrenallymphomaapopulationbasedstudyintheunitedstates19802013
AT wubian primaryrenallymphomaapopulationbasedstudyintheunitedstates19802013